Abstract: A method of manufacturing an aerosol generating rod includes providing a sheet of a first non-tobacco material by using at least one first conveying roller; crimping the sheet of the first non-tobacco material by using a first crimping device; applying an aerosol generating material to at least one surface of the sheet of the first non-tobacco material by using a first spray nozzle; applying a liquid containing a tobacco component to at least one surface of the sheet of the first non-tobacco material by using a slit nozzle; drying the sheet of the first non-tobacco material by using a drying device; and forming the aerosol generating rod by forming the sheet of the first non-tobacco material into a rod by using a rod forming device.

Abstract: Disclosed is a wireless communication system, specifically, an apparatus and method for configuring a primary cell carrier/secondary cell carrier (PCC/SCC) prioritization only based on extremely partial channel state information in a wireless communication system. Specifically, a method of operating a user equipment (UE) in a wireless communication system includes: transmitting a sounding reference signal (SRS) or channel state information (CSI) to a base station; receiving a signal from the base station on the basis of the SRS or the CSI; and estimating a number of multi-paths using a neural network for the received signal, wherein the estimating of the number of multi-paths includes: re-shaping the received signal; extracting a singular value of the reshaped signal; and estimating the number of multi-paths based on the extracted singular value.

Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.

Abstract: An aerosol generating system includes: a cavity configured to accommodate at least a portion of a cigarette; a first induction coil located around the cavity; a second induction coil located around the cavity and connected to the first induction coil in parallel; and a battery configured to supply an alternating current to the first induction coil and the second induction coil, wherein the first induction coil and the second induction coil have different resonant frequencies.

Abstract: The present disclosure provides a non-aqueous electrolyte including an additive for a non-aqueous electrolyte represented by Formula 1 below: wherein, R1 to R5 may each independently be any one selected from the group consisting of H, an alkenyl group having 2 to 20 carbon atoms, an alkynyl group having 2 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, a cycloalkyl group having 3 to 12 carbon atoms, a cycloalkenyl group having 3 to 12 carbon atoms, and a nitrile group.

Abstract: An aerosol generating device includes a first vaporizer configured to generate a first aerosol by heating a first liquid composition, a second vaporizer configured to generate a second aerosol by heating a second liquid composition, and a controller controlling power supplied to the first vaporizer and the second vaporizer, based on a first mode, in which a smokeless aerosol is generated, and a second mode, in which a transport amount of nicotine included in the second liquid composition is adjusted.

Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.

Abstract: A battery module includes a plurality of pouch-type battery cells respectively having an accommodation portion and a sealing portion and configured to be stacked on each other; a module case configured to accommodate the plurality of pouch-type battery cells in an inner space thereof; and a barrier member interposed between the accommodation portions of neighboring pouch-type battery cells and configured to have at least one side protrusively extending from a portion between the accommodation portions of the neighboring pouch-type battery cells to a portion between the sealing portions of the neighboring pouch-type battery cells.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present disclosure relates to an implant device in a shape of a natural tooth with a removable tooth root. The implant device includes an implant body having a tooth root hole formed to penetrate therethrough, an integral tooth root formed by being integrally coupled to the implant body, a removable tooth root formed to extend from the implant body while being inserted along the root hole, and a tooth root fixing unit formed to fix the removable tooth root to the implant body.

Abstract: An extraction method for nonpolar natural substances includes: a step of conducting extraction of natural raw materials to prepare a first liquid extract; a step of mixing the first liquid extract with a phase separation composition containing a lipophilic solubilizer and water, and conducting a second extraction; and a step of isolating the supernatant of the phase-separated solution to obtain non-polar natural substances.

Abstract: Embodiments of the present disclosure relate to a tissue expander that expands in a gradual manner using a controlled release of gas resulting from a chemical reaction of a reactant substance within the tissue expander. The reactant substance is initially in a liquid or solid state and is stored in an internal chamber of the tissue expander. The chemical reaction of the reactant substance produces the gas that causes the tissue expander to expand over time. The tissue expander continues to expand gradually after implanting of the tissue expander within a patient’s body and initiating of the chemical reaction.

Abstract: An extraction method for nonpolar natural substances includes: a step of conducting extraction of natural raw materials to prepare a first liquid extract; a step of mixing the first liquid extract with a phase separation composition containing a lipophilic solubilizer and water, and conducting a second extraction; and a step of isolating the supernatant of the phase-separated solution to obtain non-polar natural substances.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.

Abstract: An anti-diabetic composition is disclosed. The anti-diabetic composition includes a Smilax china L. leaf extract having no toxicity to human bodies, no side effects such as increase or decrease in body weight, and a very high ability to inhibit the activity of ?-glucosidase.